Percutaneous liver biopsy – 2 decades of experience in a public hospital in the South of Brazil
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 6
Abstract
Introduction. Liver biopsy is a complementary method for diagnosis, staging and therapeutic guidance in liver diseases, where chronic viral hepatitis are the most acknowledged causes for the indication of histopathological study. The objective is to assess the patients’ profile as well as the indication and results of percutaneous liver biopsies in a tertiary hospital. Material and methods. A descriptive, cross-section study was carried out through the review of medical charts (retrospective cohort) of patients submitted to blind percutaneous liver biopsies (PLB) at a hospital in Porto Alegre, South Brazil, from October 1993 to December 2011. Results. 1,955 PLB were carried out, the mean patients’ age was 44.8 years old, and 1,127 (57.65%) were men. Chronic hepatitis C was the main indication (60.5%), followed by HCV-HIV coinfection (12.2%) and chronic hepatitis B (3.5%). Seven cases (0.3%) had complications, without deaths. Conclusion. PLB is a safe method and continues to be an important option to assist patients with chronic liver disease.
Authors and Affiliations
Rafael Bergesch D’Incao, Marcelo Campos Appel da Silva, Paulo Roberto Lerias de Almeida, Viviane Plasse Renon, Cristiane Valle Tovo
Keywords
Related Articles
- EP ID EP78335
- DOI -
- Views 123
- Downloads 0
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection
Background. Patient race and ethnicity have historically impacted HCV treatment response. This phase 3 study evaluated daclatasvir with peginterferon-alfa-2a/ribavirin (pegIFN alfa-2a/RBV) in treatment-naive black/Afric...
Metabolic syndrome and non-alcoholic fatty liver disease
The development of nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metabolic syndrome as reflected by the fact that approximately 90% of the patients with NAFLD have more than one feature of meta...
Epidemiology of HCV infection in Latin America
Hepatitis C virus is one of the most common causes of chronic liver disease and one of the principal indications for liver transplantation. The prevalence and incidence worldwide is variable, although there may be some s...
Insulin resistance and steatosis in chronic hepatitis C
In chronic hepatitis C, insulin resistance (IR) and type 2 diabetes mellitus (DM) are more prevalent than in healthy controls or in chronic hepatitis B patients. HCV infection promotes IR mainly through increased TNF-a a...